S. de Matteis

发表

Hormonal replacement therapy after stem cell transplantation.

P. Chiusolo, G. Leone, L. Laurenti, 2004, Maturitas.

Viral infection in bone marrow transplants: Is JC virus involved?

F. Chiarini, R. Boldorini, V. Pietropaolo, 2010, Journal of medical virology.

Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis.

P. Chiusolo, S. Rutella, G. Leone, 2003, Haematologica.

Immune Recovery of Lymphocyte Subsets 6 Years after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Lymphoproliferative Diseases. A Comparison between NHL, HD and MM in Group of 149 Patients

P. Chiusolo, G. Leone, L. Laurenti, 2004, Leukemia & lymphoma.

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.

M. Baccarani, S. Paolini, G. Rosti, 2009, Blood.

NEUROLOGIC IMPROVEMENT AFTER PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN POEMS

P. Chiusolo, M. Sabatelli, A. Conte, 2009, Neurology.

Persistence of molecular remission throughout pregnancy in CML after imatinib.

F. D'Alo', G. Leone, S. Sica, 2009, Leukemia research.

Rituximab for pure red cell aplasia after ABO‐mismatched allogeneic peripheral blood progenitor cell transplantation

R. Putzulu, P. Chiusolo, G. Leone, 2005, Transfusion.

Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome.

P. Chiusolo, G. Leone, M. Sabatelli, 2008, Leukemia research.

Reliability of leukostasis grading score to identify patients with high‐risk hyperleukocytosis

P. Chiusolo, L. Pagano, G. Leone, 2009, American journal of hematology.

Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM.

P. Chiusolo, G. Leone, S. De Vita, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Granulocyte colony-stimulating factor after autologous CD34+ immunoselected peripheral blood stem cell transplantation.

G. Leone, S. Sica, N. Piccirillo, 2004, Haematologica.

Circulating hematopoietic progenitor cells after autologous stem cell transplant for hematological malignancies

P. Chiusolo, G. Leone, L. Laurenti, 2010, Leukemia & lymphoma.

ABO type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients

P. Chiusolo, G. Leone, L. Laurenti, 2008, Transfusion.

Reliability of leukostasis grading score to identify patients with high‐risk hyperleukocytosis

P. Chiusolo, L. Pagano, G. Leone, 2009, American journal of hematology.

Cellular Therapy

P. Chiusolo, S. Rutella, G. Leone, 2020, Bone Marrow Transplantation.

Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis.

P. Chiusolo, S. Rutella, G. Leone, 2003, Haematologica.

Phenotypic cure 6 years after bone marrow transplantation in a β‐thalassemia patient

P. Chiusolo, L. Pagano, G. Leone, 2009, American journal of hematology.

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.

M. Baccarani, S. Paolini, G. Rosti, 2009, Blood.